{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,2,21]],"date-time":"2025-02-21T21:47:19Z","timestamp":1740174439096,"version":"3.37.3"},"reference-count":33,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2024,10,1]],"date-time":"2024-10-01T00:00:00Z","timestamp":1727740800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,10,1]],"date-time":"2024-10-01T00:00:00Z","timestamp":1727740800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,8,11]],"date-time":"2024-08-11T00:00:00Z","timestamp":1723334400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100019779","name":"Qatar National Library","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100019779","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.fr","clinicalkey.jp","clinicalkey.com.au","clinicalkey.es","clinicalkey.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["IJC Heart & Vasculature"],"published-print":{"date-parts":[[2024,10]]},"DOI":"10.1016\/j.ijcha.2024.101493","type":"journal-article","created":{"date-parts":[[2024,8,23]],"date-time":"2024-08-23T09:06:50Z","timestamp":1724404010000},"page":"101493","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Management strategies and outcomes of thromboembolism prevention in atrial fibrillation co-existing with immune thrombocytopenia: A review of evidence"],"prefix":"10.1016","volume":"54","author":[{"ORCID":"https:\/\/orcid.org\/0009-0008-6057-7000","authenticated-orcid":false,"given":"Omar H.","family":"Metwally","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alaa","family":"Rahhal","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Raghad A.","family":"Elsherif","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ahmed M.","family":"Elshoeibi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mohamed","family":"Elhadary","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Amgad M.","family":"Elshoeibi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ahmed","family":"Badr","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Basel","family":"Elsayed","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mona","family":"Al- Rasheed","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Awni","family":"Alshurafa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1144-8076","authenticated-orcid":false,"given":"Mohamed A.","family":"Yassin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"12","key":"10.1016\/j.ijcha.2024.101493_b0005","doi-asserted-by":"crossref","first-page":"1447","DOI":"10.1136\/heart.89.12.1447","article-title":"The role of echocardiography in atrial fibrillation and cardioversion","volume":"89","author":"Troughton","year":"2003","journal-title":"Heart"},{"issue":"3","key":"10.1016\/j.ijcha.2024.101493_b0010","first-page":"179","article-title":"Predisposing factors for atrial fibrillation in the elderly","volume":"14","author":"Wasmer","year":"2017","journal-title":"J. Geriatr Cardiol"},{"issue":"10","key":"10.1016\/j.ijcha.2024.101493_b0015","doi-asserted-by":"crossref","first-page":"946","DOI":"10.1161\/01.CIR.98.10.946","article-title":"Impact of atrial fibrillation on the risk of death: the Framingham heart study","volume":"98","author":"Benjamin","year":"1998","journal-title":"Circulation"},{"issue":"2","key":"10.1016\/j.ijcha.2024.101493_b0020","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1016\/S0735-1097(00)01107-4","article-title":"Epidemiology and natural history of atrial fibrillation: clinical implications","volume":"37","author":"Chugh","year":"2001","journal-title":"J. Am Coll. Cardiol"},{"issue":"23","key":"10.1016\/j.ijcha.2024.101493_b0025","doi-asserted-by":"crossref","first-page":"2371","DOI":"10.1161\/CIRCULATIONAHA.114.008201","article-title":"Contemporary trends of hospitalization for atrial fibrillation in the United States, 2000 through 2010: implications for healthcare planning","volume":"129","author":"Patel","year":"2014","journal-title":"Circulation"},{"issue":"1","key":"10.1016\/j.ijcha.2024.101493_b0030","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1161\/01.CIR.0000022730.66617.D9","article-title":"Cardiology patient page. Atrial fibrillation","volume":"106","author":"Waktare","year":"2002","journal-title":"Circulation"},{"issue":"25","key":"10.1016\/j.ijcha.2024.101493_b0035","doi-asserted-by":"crossref","first-page":"3360","DOI":"10.1016\/j.jacc.2019.04.039","article-title":"Valvular atrial fibrillation: a confusing and obsolete definition","volume":"73","author":"Giancaterino","year":"2019","journal-title":"J. Am. Coll. Cardiol."},{"issue":"3","key":"10.1016\/j.ijcha.2024.101493_b0040","doi-asserted-by":"crossref","first-page":"792","DOI":"10.1161\/01.CIR.82.3.792","article-title":"Atrial enlargement as a consequence of atrial fibrillation. A Prospective echocardiographic study","volume":"82","author":"Sanfilippo","year":"1990","journal-title":"Circulation"},{"issue":"7","key":"10.1016\/j.ijcha.2024.101493_b0045","doi-asserted-by":"crossref","first-page":"688","DOI":"10.1001\/jama.2019.10925","article-title":"Electrocardiographic diagnosis of atrial arrhythmias","volume":"322","author":"Soliman","year":"2019","journal-title":"JAMA"},{"issue":"5","key":"10.1016\/j.ijcha.2024.101493_b0050","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1093\/eurheartj\/ehaa612","volume":"42","author":"Hindricks","year":"2021","journal-title":"Eur. Heart J."},{"issue":"5","key":"10.1016\/j.ijcha.2024.101493_b0055","doi-asserted-by":"crossref","first-page":"1121","DOI":"10.1016\/j.chest.2018.07.040","article-title":"Antithrombotic therapy for atrial fibrillation: CHEST guideline and expert panel report","volume":"154","author":"Lip","year":"2018","journal-title":"Chest"},{"issue":"6","key":"10.1016\/j.ijcha.2024.101493_b0060","first-page":"442","article-title":"Diagnosis and treatment of atrial fibrillation","volume":"94","author":"Gutierrez","year":"2016","journal-title":"Am Fam. Physician"},{"issue":"38","key":"10.1016\/j.ijcha.2024.101493_b0065","doi-asserted-by":"crossref","first-page":"2893","DOI":"10.1093\/eurheartj\/ehw210","article-title":"2016 ESC Guidelines for the management of atrial fibrillation developed in collaboration with EACTS","volume":"37","author":"Kirchhof","year":"2016","journal-title":"Eur. Heart J."},{"issue":"11","key":"10.1016\/j.ijcha.2024.101493_b0070","doi-asserted-by":"crossref","first-page":"2386","DOI":"10.1182\/blood-2008-07-162503","article-title":"Standardization of terminology, definitions and outcome criteria in immune thrombocytopenic purpura of adults and children: report from an international working group","volume":"113","author":"Rodeghiero","year":"2009","journal-title":"Blood"},{"issue":"11","key":"10.1016\/j.ijcha.2024.101493_b0075","doi-asserted-by":"crossref","first-page":"2377","DOI":"10.1111\/j.1538-7836.2006.02147.x","article-title":"Prevalence of immune thrombocytopenia: analyses of administrative data","volume":"4","author":"Segal","year":"2006","journal-title":"J. Thromb Haemost"},{"issue":"3","key":"10.1016\/j.ijcha.2024.101493_b0080","doi-asserted-by":"crossref","first-page":"495","DOI":"10.1016\/j.hoc.2013.03.001","article-title":"Immune thrombocytopenia","volume":"27","author":"Kistangari","year":"2013","journal-title":"Hematol Oncol Clin. North Am"},{"key":"10.1016\/j.ijcha.2024.101493_b0085","doi-asserted-by":"crossref","first-page":"45","DOI":"10.12703\/P6-45","article-title":"Management of thrombocytopenia","volume":"6","author":"Izak","year":"2014","journal-title":"F1000Prime Rep"},{"issue":"16","key":"10.1016\/j.ijcha.2024.101493_b0090","doi-asserted-by":"crossref","first-page":"4190","DOI":"10.1182\/blood-2010-08-302984","article-title":"The American Society of Hematology 2011 evidence-based practice guideline for immune thrombocytopenia","volume":"117","author":"Neunert","year":"2011","journal-title":"Blood"},{"issue":"22","key":"10.1016\/j.ijcha.2024.101493_b0095","doi-asserted-by":"crossref","first-page":"3780","DOI":"10.1182\/bloodadvances.2019000812","article-title":"Updated international consensus report on the investigation and management of primary immune thrombocytopenia","volume":"3","author":"Provan","year":"2019","journal-title":"Blood Adv."},{"issue":"3","key":"10.1016\/j.ijcha.2024.101493_b0100","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1097\/FJC.0000000000000607","article-title":"Non-Vitamin K Antagonist Oral Anticoagulants in Patients With Atrial Fibrillation and Thrombocytopenia","volume":"72","author":"Janion-Sadowska","year":"2018","journal-title":"J. Cardiovasc Pharmacol"},{"issue":"4","key":"10.1016\/j.ijcha.2024.101493_b0105","doi-asserted-by":"crossref","first-page":"717","DOI":"10.36660\/abc.20190599","article-title":"Thrombocytopenia-related problems in patients with concomitant atrial fibrillation requiring antithrombotic prevention: a retrospective cohort study","volume":"115","author":"Vecchis","year":"2020","journal-title":"Arq. Bras. Cardiol."},{"issue":"21","key":"10.1016\/j.ijcha.2024.101493_b0110","doi-asserted-by":"crossref","first-page":"e012596","DOI":"10.1161\/JAHA.119.012596","article-title":"Thrombocytopenia and mortality risk in patients with atrial fibrillation: an analysis from the START registry","volume":"8","author":"Pastori","year":"2019","journal-title":"J. Am. Heart Assoc."},{"issue":"4","key":"10.1016\/j.ijcha.2024.101493_b0115","doi-asserted-by":"crossref","first-page":"512","DOI":"10.1007\/s11239-018-1792-1","article-title":"Effectiveness and safety of non-vitamin-K antagonist oral anticoagulants versus warfarin in atrial fibrillation patients with thrombocytopenia","volume":"47","author":"Wang","year":"2019","journal-title":"J. Thromb Thrombolysis"},{"issue":"3","key":"10.1016\/j.ijcha.2024.101493_b0120","doi-asserted-by":"crossref","first-page":"242","DOI":"10.3109\/09537104.2012.686074","article-title":"Long-term follow-up of concomitant treatment with romiplostim and warfarin in a patient with immune thrombocytopenia and severe cardiac comorbidities","volume":"24","author":"Baldini","year":"2013","journal-title":"Platelets"},{"issue":"5","key":"10.1016\/j.ijcha.2024.101493_b0125","doi-asserted-by":"crossref","first-page":"639","DOI":"10.1111\/j.1365-2141.2012.09051.x","article-title":"Immune thrombocytopenia and anticoagulation: the role of romiplostim in the early treatment","volume":"157","author":"Cantoni","year":"2012","journal-title":"Br. J. Haematol."},{"issue":"2","key":"10.1016\/j.ijcha.2024.101493_b0130","doi-asserted-by":"crossref","first-page":"e15","DOI":"10.1016\/j.jcin.2017.11.008","article-title":"Thrombosis of a left atrial appendage occluder after treatment with thrombopoietin receptor agonists","volume":"11","author":"Cubero-Gallego","year":"2018","journal-title":"JACC Cardiovasc. Interv."},{"issue":"2","key":"10.1016\/j.ijcha.2024.101493_b0135","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1007\/s10840-021-01073-0","article-title":"Percutaneous left atrial appendage closure in patients with primary hemostasis disorders and atrial fibrillation","volume":"64","author":"Dognin","year":"2022","journal-title":"J. Interv Card Electrophysiol"},{"issue":"3","key":"10.1016\/j.ijcha.2024.101493_b0140","doi-asserted-by":"crossref","DOI":"10.1136\/bcr-2021-241985","article-title":"Challenges of left atrial appendage closure device and anticoagulation in a patient with immune thrombocytopenia (ITP)","volume":"14","author":"Uddin","year":"2021","journal-title":"BMJ Case Rep"},{"issue":"1","key":"10.1016\/j.ijcha.2024.101493_b0145","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1016\/j.jacc.2019.01.011","volume":"74","author":"January","year":"2019","journal-title":"J. Am. Coll. Cardiol."},{"issue":"14","key":"10.1016\/j.ijcha.2024.101493_b0150","first-page":"e506","article-title":"2015 ACC\/AHA\/HRS guideline for the management of adult patients with supraventricular tachycardia: a report of the american college of cardiology\/american heart association task force on clinical practice guidelines and the heart rhythm society","volume":"133","author":"Page","year":"2016","journal-title":"Circulation"},{"issue":"15","key":"10.1016\/j.ijcha.2024.101493_b0155","doi-asserted-by":"crossref","first-page":"1763","DOI":"10.1161\/CIRCULATIONAHA.118.037564","article-title":"Effectively initiating and maintaining anticoagulation in patients with atrial fibrillation","volume":"139","author":"Wang","year":"2019","journal-title":"Circulation"},{"issue":"10","key":"10.1016\/j.ijcha.2024.101493_bib156","article-title":"Immune Thrombocytopenic Purpura and Paradoxical Thrombosis: A Systematic Review of Case Reports","volume":"14","author":"Ali","year":"2022","journal-title":"Cureus"},{"key":"10.1016\/j.ijcha.2024.101493_bib157","doi-asserted-by":"crossref","first-page":"1348941","DOI":"10.3389\/fmed.2024.1348941","article-title":"A practical guide to the management of immune thrombocytopenia co-existing with acute coronary syndrome","volume":"11","author":"Rahhal","year":"2024","journal-title":"Frontiers in medicine"}],"container-title":["IJC Heart & Vasculature"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2352906724001593?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2352906724001593?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,9,18]],"date-time":"2024-09-18T06:02:56Z","timestamp":1726639376000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2352906724001593"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,10]]},"references-count":33,"alternative-id":["S2352906724001593"],"URL":"https:\/\/doi.org\/10.1016\/j.ijcha.2024.101493","relation":{},"ISSN":["2352-9067"],"issn-type":[{"type":"print","value":"2352-9067"}],"subject":[],"published":{"date-parts":[[2024,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Management strategies and outcomes of thromboembolism prevention in atrial fibrillation co-existing with immune thrombocytopenia: A review of evidence","name":"articletitle","label":"Article Title"},{"value":"IJC Heart & Vasculature","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ijcha.2024.101493","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 The Author(s). Published by Elsevier B.V.","name":"copyright","label":"Copyright"}],"article-number":"101493"}}